The functional interplay was further confirmed by the in vivo tumor xenograft experiment (Supplementary Fig. S5A–E), which showed that BARX1 overexpression promoted tumor progression, and importantly, ZFP36 significantly attenuates BARX1-mediated tumor progression in vivo. Here, BARX1 is linked to neoplasm.